Results 51 to 60 of about 2,415 (163)
Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
The Journal of Dermatology, Volume 53, Issue 5, Page 758-773, May 2026.ABSTRACT Vitiligo is a chronic autoimmune depigmenting disease characterized by loss of pigment in the skin, hair, or both. As treatment options evolve, particularly with the emergence of oral Janus kinase inhibitors and dual Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor, it is essential to assess ...
Kennedy Cook +11 more
wiley +1 more source
A Multifaceted Holistic Review of the Literature on Scar Dermatoses
International Wound Journal, Volume 23, Issue 5, May 2026.ABSTRACT Many cutaneous diseases originate or manifest in scars. Scars are areas of compromised skin, which renders them a vulnerable cutaneous district for diseases to develop. The pathophysiology explaining why some dermatoses grow in scars is not yet thoroughly explored. The present study reviews the present literature on scar dermatoses.
Dana Maria Khoury +5 more
wiley +1 more source
Developmental Medicine &Child Neurology, Volume 68, Issue 3, Page 441-452, March 2026.Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.70022 This original article is commented on by Scelsa on pages 311–312 of this issue. Abstract Aim To examine the accuracy of prenatal counselling at a multidisciplinary fetal neurology clinic (FNC) that led to termination of pregnancy (TOP), to improve the quality of future ...
Avi Shariv +12 more
wiley +1 more source
Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips
Advanced Biology, Volume 10, Issue 2, February 2026.Buck and Bugter et al. explore the architectural diversity and physiological functions of human barrier systems and reveal how organ‐on‐chip platforms, particularly those integrating patient‐derived cells, are advancing barrier disease modeling. They highlight how emerging biological and technological advances can be used to bridge the gap between ...
Franziska Buck +4 more
wiley +1 more source
Genética Molecular das Epidermólises Bolhosas Molecular Genetics of Epidermolysis Bullosa
Anais Brasileiros de Dermatologia, 2002 O estudo das alterações moleculares das epidermólises bolhosas tem contribuído para que se compreenda melhor essas enfermidades. Na epidermólise bolhosa simples a maioria dos casos está associada com alteração nas citoqueratinas basais 5 (gen KRT5) e 14 (
Hiram Larangeira de Almeida Jr
doaj +1 more source
Clinical Case Reports, Volume 14, Issue 1, January 2026.Ultrasonographic characteristics of fetal junctional epidermolysis bullosa associated with ITGB4 gene mutation. ABSTRACT Homozygous or compound heterozygous mutations in the ITGB4 gene are associated with the pathogenesis of junctional epidermolysis bullosa, characterized by increased fragility of the skin and mucous membranes.
Qi Xu +7 more
wiley +1 more source
Case Reports in Dermatological Medicine, Volume 2026, Issue 1, 2026.Background Inherited epidermolysis bullosa (EB) is a rare group of monogenic disorders causing skin fragility. Junctional EB is the rarest subtype, caused by mutations in genes like COL17A1. Type 1 diabetes mellitus (DM) is a polygenic autoimmune disease.
Amir Abadi +3 more
wiley +1 more source
Stem Cell Research, 2019 We have generated MLi002-A, a new induced pluripotent stem cell (iPSC) line derived from keratinocytes of a skin punch biopsy of a female patient with the severe epidermolysis bullosa simplex Dowling-Meara phenotype and the keratin K5 E475G mutation ...
Nikola Kolundzic +7 more
doaj +1 more source
PAIN MANAGEMENT OF NEWBORN WITH EPIDERMOLYSIS BULLOSA FOR WOUND DRESSING: A CASE REPORT
Sanamed, 2020 Epidermolysis bullosa (EB) is a genetic disease characterized by blisters on the skin and mucous membranes as a result of mechanical fragility. There are four types of EB: simplex (EBS), junctional (JEB), dystrophic forms (DEB), and Kindler syndrome ...
Sevgi Balli Seyhan
doaj +1 more source
Nail Dystrophy Treated With Marigold Therapy in a Patient With Epidermolysis Bullosa Simplex
Australasian Journal of Dermatology, Volume 67, Issue 4, Page e255-e256, June 2026.
Aalia Syed +2 more
wiley +1 more source